Prevention and Management of Denosumab Discontinuation Rebound Fractures
S Jain - Endocrinology and Metabolism Clinics, 2024 - endo.theclinics.com
Background Denosumab rebound-associated vertebral fractures (RAVFs) are a clinical
phenomenon of multiple new vertebral fractures that occur with discontinuation or delay of …
phenomenon of multiple new vertebral fractures that occur with discontinuation or delay of …
Clinical experience with denosumab discontinuation
N Laursen, AS Sølling, T Harsløf, B Langdahl - Osteoporosis International, 2025 - Springer
In patients receiving long-term treatment with denosumab, denosumab discontinuation via
sequential treatment with zoledronate, resulted in a minor decrease in bone mass density …
sequential treatment with zoledronate, resulted in a minor decrease in bone mass density …
Denosumab discontinuation: COVID-19 pandemic and beyond
S Minisola - JBMR plus, 2024 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic triggered significant
disruptions in health care systems around the world, with a particularly heavy impact on …
disruptions in health care systems around the world, with a particularly heavy impact on …
What's New in Osteoporosis: Emphasis on the Aging Athlete
The contemporary treatment of osteoporosis has seen tremendous evolution. Today, we
have access to powerful biologic agents for the treatment of osteoporosis and an improved …
have access to powerful biologic agents for the treatment of osteoporosis and an improved …